Deep-tissue localization of magnetic field hyperthermia using pulse sequencing

References

• Gilchrist RK, Medal R, Shorey WD, et al. Selective inductive heating of lymph nodes. Ann Surg. 1957;146(4):596–606.
   PubMed Web of Science ®Google Scholar
• Hilger I, Hergt R, Kaiser WA. Towards breast cancer treatment by magnetic heating. J Magn Magn Mater. 2005;293(1):314–319.
   Web of Science ®Google Scholar
• Maier-Hauff K, Jordan A, Nestler D, et al. Magnetic Fluid Hyperthermia (MFH) as an alternative treatment of malignant gliomas. Strahlenther Onkol. 2005;181:44.
   Web of Science ®Google Scholar
• Hergt R, Dutz S, Muller R, et al. Magnetic particle hyperthermia: nanoparticle magnetism and materials development for cancer therapy. J Phys: Condens Matter. 2006;18(38):S2919–S34.
   Web of Science ®Google Scholar
• Ludwig R, Stapf M, Dutz S, et al. Structural properties of magnetic nanoparticles determine their heating behavior – an estimation of the in vivo heating potential. Nanoscale Res Lett. 2014;9(1):602.
   PubMed Web of Science ®Google Scholar
• Salloum M, Ma RH, Zhu L. An in-vivo experimental study of temperature elevations in animal tissue during magnetic nanoparticle hyperthermia. Int J Hyperthermia. 2008;24(7):589–601.
   PubMed Web of Science ®Google Scholar
• Hildebrandt B, Wust P, Ahlers O, et al. The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hemat. 2002;43(1):33–56.
   PubMed Web of Science ®Google Scholar
• Mello PD, Bian S, Savio LEB, et al. Hyperthermia and associated changes in membrane fluidity potentiate P2X7 activation to promote tumor cell death. Oncotarget. 2017;8(40):67254–67268.
   PubMedGoogle Scholar
• Flanagan SW, Moseley PL, Buettner GR. Increased flux of free radicals in cells subjected to hyperthermia: detection by electron paramagnetic resonance spin trapping. FEBS Lett. 1998;431(2):285–286.
   PubMed Web of Science ®Google Scholar
• Katschinski DM, Boos K, Schindler SG, et al. Pivotal role of reactive oxygen species as intracellular mediators of hyperthermia-induced apoptosis. J Biol Chem. 2000;275(28):21094–21098.
   PubMed Web of Science ®Google Scholar
• Ludwig R, Teran FJ, Teichgraeber U, et al. Nanoparticle-based hyperthermia distinctly impacts production of ROS, expression of Ki-67, TOP2A, and TPX2, and induction of apoptosis in pancreatic cancer. Int J Nanomedicine. 2017;12:1009–1018.
   PubMed Web of Science ®Google Scholar
• Sanhaji M, Goring J, Couleaud P, et al. The phenotype of target pancreatic cancer cells influences cell death by magnetic hyperthermia with nanoparticles carrying gemicitabine and the pseudo-peptide NucAnt. Nanomed-Nanotechnol. 2019;20:101983.
   PubMed Web of Science ®Google Scholar
• The European Union Horizon. 2020. project “NoCanTher” is a collaboration between 8 academic and 3 commercial partners focussed on magnetic hyperthermia as a treatment for pancreatic cancer; [cited 2021 Apr 06]. Available from: http://www.nocanther-project-eu.
   Google Scholar
• Gibson-Corley KN, Olivier AK, Meyerholz DK. Principles for valid histopathologic scoring in research. Vet Pathol. 2013;50(6):1007–1015.
   PubMed Web of Science ®Google Scholar
• Huang H-W, Horng T-L. Heat transfer and fluid flow in biological processes. In: Becker SM, Kuznetsov AV, editor. Worldcat. Boston: Academic Press; 2015. p. 1–42.
   Google Scholar
• Wright NT. Heat transfer and fluid flow in biological processes. Boston: Academic Press; 2015. p. 59–76.
   Google Scholar
• Hasgall PA, Di Gennaro F, Baumgartner C, et al. It’s Database for thermal and electromagnetic parameters of biological tissues. Version 40. 2018; May 15, 2018.
   Google Scholar
• Kandala SK, Liapi E, Whitcomb LL, et al. Temperature-controlled power modulation compensates for heterogeneous nanoparticle distributions: a computational optimization analysis for magnetic hyperthermia. Int J Hyperthermia. 2019;36(1):115–129.
   PubMed Web of Science ®Google Scholar
• Reis RF, Loureiro FD, Lobosco M. 3D numerical simulations on GPUs of hyperthermia with nanoparticles by a nonlinear bioheat model. J Comput Appl Math. 2016;295:35–47.
   Web of Science ®Google Scholar
• Chavez JA, Ortega JA, Salazar J, et al. SPICE model of thermoelectric elements including thermal effects. Proceedings of the 17th IEEE Instrumentation and Measurement Technology Conference (Cat No 00CH37066). 2000. 2:1019–23.
   Google Scholar
• Gao F, Zheng Q, Zheng YJ. Electrical circuit modeling and analysis of microwave acoustic interaction with biological tissues. Med Phys. 2014;41(5):053302.
   PubMed Web of Science ®Google Scholar
• Ting-Yuan W, Charlie Chung-Ping C. SPICE-compatible thermal simulation with lumped circuit modeling for thermal reliability analysis based on modeling order reduction. International Symposium on Signals, Circuits and Systems Proceedings, SCS 2003 (Cat No 03EX720). 2004:357–62.
   Google Scholar
• Sapareto SA. Thermal Isoeffect dose: addressing the problem of thermotolerance. Int J Hyperthermia. 1987;3(4):297–305.
   PubMed Web of Science ®Google Scholar
• Sapareto SA, Dewey WC. Thermal dose determination in cancer-therapy. Int J Radiat Oncol. 1984;10(6):787–800.
   PubMed Web of Science ®Google Scholar
• Pearce JA. Relationship between Arrhenius models of thermal damage and the CEM 43 thermal dose. Proceedings SPIE. 2009. 7181:718104.
   Google Scholar
• Dahring H, Grandke J, Teichgraber U, et al. Improved hyperthermia treatment of tumors under consideration of magnetic nanoparticle distribution using micro-CT imaging. Mol Imaging Biol. 2015;17(6):763–769.
   PubMed Web of Science ®Google Scholar
• Kossatz S, Ludwig R, Dahring H, et al. High therapeutic efficiency of magnetic hyperthermia in xenograft models achieved with moderate temperature dosages in the tumor area. Pharm Res. 2014;31(12):3274–3288.
   PubMed Web of Science ®Google Scholar
• Wust P, Gneveckow U, Johannsen M, et al. Magnetic nanoparticles for interstitial thermotherapy-feasibility, tolerance and achieved temperatures. Int J Hyperthermia. 2006;22(8):673–685.
   PubMed Web of Science ®Google Scholar
• Dhakal HP, Bassarova A, Naume B, et al. Breast carcinoma vascularity: a comparison of manual microvessel count and Chalkley count. Histol Histopathol. 2009;24(8):1049–1059.
   PubMed Web of Science ®Google Scholar
• Davis AK, Maney DL, Maerz JC. The use of leukocyte profiles to measure stress in vertebrates: a review for ecologists. Funct Ecol. 2008;22(5):760–772.
   Web of Science ®Google Scholar
• Yarmolenko PS, Moon EJ, Landon C, et al. Thresholds for thermal damage to normal tissues: an update. Int J Hyperthermia. 2011;27(4):320–343.
   PubMed Web of Science ®Google Scholar
• Gonzalez RJ, Tarloff JB. Evaluation of hepatic subcellular fractions for Alamar blue and MTT reductase activity. Toxicol in Vitro. 2001;15(3):257–259.
   PubMed Web of Science ®Google Scholar
• Begg AC, Stewart FA, Vens C. Genomic instability in cancer strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer. 2011;11(4):239–253.
   PubMed Web of Science ®Google Scholar
• Moritz AR, Henriques FC. Studies of thermal injury.2. the relative importance of time and surface temperature in the causation of cutaneous burns. Am J Pathol. 1947;23(5):695–720.
   PubMed Web of Science ®Google Scholar
• Philip PA, Lacy J, Portales F, et al. Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study. Lancet Gastroenterol Hepatol. 2020;5(3):285–294.
   PubMed Web of Science ®Google Scholar
• Tentes AA, Stamou K, Pallas N, et al. The effect of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) as an adjuvant in patients with resectable pancreatic cancer. Int J Hyperthermia. 2016;32(8):895–899.
   PubMed Web of Science ®Google Scholar
• Fiorentini G, Sarti D, Casadei V, et al. Modulated electro-hyperthermia as palliative treatment for pancreatic cancer: a retrospective observational study on 106 patients. Integr Cancer Ther. 2019;18:153473541987850.
   Web of Science ®Google Scholar
• Hilger I. In vivo applications of magnetic nanoparticle hyperthermia. Int J Hyperthermia. 2013;29(8):828–834.
   PubMed Web of Science ®Google Scholar
• Hiraoka M, Jo S, Akuta K, et al. Radiofrequency capacitive hyperthermia for deep-seated tumors.1. studies on thermometry. Cancer. 1987;60(1):121–127.
   PubMed Web of Science ®Google Scholar
• Andra W, d’Ambly CG, Hergt R, et al. Temperature distribution as function of time around a small spherical heat source of local magnetic hyperthermia. J Magn Magn Mater. 1999;194(1–3):197–203.
   Web of Science ®Google Scholar
• Ivkov R, DeNardo SJ, Daum W, et al. Application of high amplitude alternating magnetic fields for heat induction of nanoparticles localized in cancer. Clin Cancer Res. 2005;11(19):7093s–70103.
   PubMed Web of Science ®Google Scholar
• European Cooperation in Science and Technology project. RADIOMAG TD1402; [cited 2021 Apr 06]. Available from: http://www.cost-radiomag.eu.
   Google Scholar
• Makridis A, Tziomaki M, Topouridou K, et al. A novel strategy combining magnetic particle hyperthermia pulses with enhanced performance binary ferrite carriers for effective in vitro manipulation of primary human osteogenic sarcoma cells. Int J Hyperthermia. 2016;32(7):778–785.
   PubMed Web of Science ®Google Scholar
• Tang XZ, Xu YJ, Chen J, et al. Intermittent time-set technique controlling the temperature of magnetic-hyperthermia-ablation for tumor therapy. RSC Adv. 2018;8(30):16410–16418.
   PubMed Web of Science ®Google Scholar
• Hyun DC. Magnetically-controlled, pulsatile drug release from poly(epsilon-caprolactone) (PCL) particles with hollow interiors. Polymer. 2015;74:159–165.
   Web of Science ®Google Scholar
• Oliveira RR, Carriao MS, Pacheco MT, et al. Triggered release of paclitaxel from magnetic solid lipid nanoparticles by magnetic hyperthermia. Mater Sci Eng C Mater Biol Appl. 2018;92:547–553.
   PubMed Web of Science ®Google Scholar
• Lin XJ, Howell SB. Effect of loss of DNA mismatch repair on development of topotecan-, gemcitabine-, and paclitaxel-resistant variants after exposure to cisplatin. Mol Pharmacol. 1999;56(2):390–395.
   PubMed Web of Science ®Google Scholar
• Kampinga HH, Dynlacht JR, Dikomey E. Mechanism of radiosensitization by hyperthermia (> or = 43 degrees C) as derived from studies with DNA repair defective mutant cell lines. Int J Hyperthermia. 2004;20(2):131–139.
   PubMed Web of Science ®Google Scholar
• Alvarez-Berrios MP, Castillo A, Mendez J, et al. Hyperthermic potentiation of cisplatin by magnetic nanoparticle heaters is correlated with an increase in cell membrane fluidity. Int J Nanomed. 2013;8:1003–1013.
   PubMed Web of Science ®Google Scholar
• Dewey WC, Hopwood LE, Sapareto SA, et al. Cellular responses to combinations of hyperthermia and radiation. Radiology. 1977;123(2):463–474.
   PubMed Web of Science ®Google Scholar
• Lertkiatmongkol P, Liao DY, Mei H, et al. Endothelial functions of platelet/endothelial cell adhesion molecule-1 (CD31). Curr Opin Hematol. 2016;23(3):253–259.
   PubMed Web of Science ®Google Scholar
• Liu L, Shi GP. CD31: beyond a marker for endothelial cells. Cardiovasc Res. 2012;94(1):3–5.
   PubMed Web of Science ®Google Scholar
• Hegewisch-Becker S, Braun K, Otte M, et al. Effects of whole body hyperthermia (41.8 degrees C) on the frequency of tumor cells in the peripheral blood of patients with advanced malignancies. Clin Cancer Res. 2003;9(6):2079–2084.
   PubMed Web of Science ®Google Scholar
• Melero JT, Ortega FG, Gonzalez AM, et al. Prognostic factor analysis of circulating tumor cells in peripheral blood of patients with peritoneal carcinomatosis of colon cancer origin treated with cytoreductive surgery plus an intraoperative hyperthermic intraperitoneal chemotherapy procedure (CRS + HIPEC). Surgery. 2016;159(3):728–735.
   PubMed Web of Science ®Google Scholar
• Follenius M, Brandenberger G, Oyono S, et al. Cortisol as a sensitive index of heat-intolerance. Physiol Behav. 1982;29(3):509–513.
   PubMed Web of Science ®Google Scholar
• Southern P, Pankhurst QA. Commentary on the clinical and preclinical dosage limits of interstitially administered magnetic fluids for therapeutic hyperthermia based on current practice and efficacy models. Int J Hyperthermia. 2017;34(6):671–686.
   PubMed Web of Science ®Google Scholar